Andrew Cameron, Ph.D.

Contact Information

Biography

Professional Background

Andrew Cameron, Ph.D., is a faculty member in the Department of Pathology and Laboratory Medicine and Assistant Director of the Clinical Microbiology Laboratories at the UR Medicine Central Laboratory. As a board-certified Clinical Microbiologist, he is a Diplomate of the American Board of Medical Microbiology.

Dr. Cameron completed his Ph.D at the University of British Columbia, Vancouver, BC, Canada, where he studied the pathogenesis and high-frequency variation of the gastrointestinal pathogen Campylobacter jejuni. He completed post-doctoral training at the University of Calgary and the Government of Canada, where he studied the genomics of bacterial pathogens. Most recently, Dr. Cameron completed a Fellowship in Medical and Public Health Microbiology at the University of Rochester Medical Center.

Research

Dr. Cameron has >10 years' experience in microbiology research. His research interests include whole-genome sequencing and comparative genomics of bacterial pathogens. He is currently involved in whole-genome sequencing of SARS-CoV-2.

Credentials

Education

2009
BSc | Canada - University of British Columbia
Microbiology and Immunology

2015
PhD | Canada - University of British Columbia
Microbiology and Immunology

Post-doctoral Training & Residency

2019 - 2021
CPEP Medical and Public Health Microbiology (American Society for Microbiology). University of Rochester Medical Center

2016 - 2019
Post-doctoral Fellowship (Natural Sciences and Engineering Research Council of Canada). University of Calgary

2015 - 2019
Post-doctoral Research Program (Agriculture and Agri-Food Canada). Government of Canada

VIEW ALL

Publications

Journal Articles

4/27/2022
Cameron A, Bohrhunter JL, Porterfield CA, Mangat R, Karasick MH, Pearson Z, Angeloni S, Pecora ND. "Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer." Microbiology spectrum.. 2022 Apr 27; 10(2):e0250721. Epub 2022 Apr 07.

4/1/2022
Kaur H, Reyes-Barron C, Sipprell WH, Cameron A, Louie T, Tsai PR, Scott G. "Painful Purulent Nodules Caused by Mycobacterium at Site of Lipodissolve Injections." The American Journal of dermatopathology.. 2022 Apr 1; 44(4):257-259.

1/29/2022
Wang J, Li D, Cameron A, Zhou Q, Wiltse A, Nayak J, Pecora ND, Zand MS. "IgG Against Human ?-Coronavirus Spike Proteins Correlates with SARS-CoV-2 anti-Spike IgG Responses and COVID-19 Disease Severity." The Journal of infectious diseases.. 2022 Jan 29; Epub 2022 Jan 29.

VIEW ALL PUBLICATIONS